| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/22/1998 | WO1998002541A1 Gamma-heregulin |
| 01/22/1998 | WO1998002538A1 Melanoma associated peptide analogues and vaccines against melanoma |
| 01/22/1998 | WO1998002530A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/22/1998 | WO1998002523A1 Vaccine preparations |
| 01/22/1998 | WO1998002463A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FCα RECEPTOR ANTIBODIES |
| 01/22/1998 | WO1998002462A1 Immunoglobulin superfamily domains and fragments with increased solubility |
| 01/22/1998 | WO1998002459A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | WO1998002457A1 Subunit respiratory syncytial virus vaccine preparation |
| 01/22/1998 | WO1998002240A1 Preservation by foam formation |
| 01/22/1998 | WO1998002180A1 Two-step immunization procedure against the pyramyxoviridae family of viruses using attenuated viral strains and subunit protein preparation |
| 01/22/1998 | WO1998002179A1 Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation |
| 01/22/1998 | WO1998002144A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | WO1996020698A3 Surface-modified nanoparticles and method of making and using same |
| 01/22/1998 | CA2436126A1 Subunit respiratory syncytial virus vaccine preparation |
| 01/22/1998 | CA2267620A1 Immunoglobulin superfamily domains and fragments with increased solubility |
| 01/22/1998 | CA2260738A1 Human monocyte chemotactic proprotein |
| 01/22/1998 | CA2260284A1 Compositions containing at least one nucleic acid |
| 01/22/1998 | CA2260233A1 A scalable method of preserving biologically active materials by desiccation |
| 01/22/1998 | CA2260107A1 Two-step immunization procedure against the pyramyxoviridae family of viruses using attenuated viral strains and subunit protein preparation |
| 01/22/1998 | CA2260082A1 Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation |
| 01/22/1998 | CA2260079A1 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 01/22/1998 | CA2259371A1 Therapeutic multispecific compounds comprised of anti-fc.alpha. receptor antibodies |
| 01/22/1998 | CA2257823A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/22/1998 | CA2257822A1 Infectious papillomavirus pseudoviral particles |
| 01/21/1998 | EP0819177A1 Expression library immunization |
| 01/21/1998 | EP0819171A1 Antibodies for the detection of hla-g |
| 01/21/1998 | EP0819168A1 Human tumor necrosis factor receptor |
| 01/21/1998 | EP0819167A2 Dna encoding galanin galr2 receptors and uses thereof |
| 01/21/1998 | EP0701612B1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS |
| 01/21/1998 | EP0620827B1 Process for producing native,intravenously administrable stabilised immunoglobin |
| 01/21/1998 | EP0528859B1 Oral vaccine comprising antigen surface-associated with red blood cells |
| 01/21/1998 | EP0504363B1 PURIFIED IgG ANTIBODIES |
| 01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
| 01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
| 01/21/1998 | CN1171054A Compound |
| 01/21/1998 | CN1171053A Vaccine adjuvants |
| 01/21/1998 | CN1171052A Vaccine adjuvants |
| 01/21/1998 | CN1170760A Improvements in sustainable cell line for production of Marek's Disease Vaccines |
| 01/20/1998 | US5710266 Nucleic acid encoding an interleukin 4 signal transducer |
| 01/20/1998 | US5710262 Nucleic acid encoding HB15 polypeptides |
| 01/20/1998 | US5710257 Method of causing selective immunosuppression using HL-60-related lectins |
| 01/20/1998 | US5710256 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels |
| 01/20/1998 | US5710137 Nucleic acids and gene expression for cancer cells |
| 01/20/1998 | US5710135 Anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/20/1998 | US5710134 Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders |
| 01/20/1998 | US5710131 Protein isolated from extract of hirudo medicinalis (leech) |
| 01/20/1998 | US5710022 Nuclear mitotic phosphoprotein |
| 01/20/1998 | US5710017 DNA encoding a constitutive activator retinoic acid response (CAR) receptor |
| 01/20/1998 | US5710010 Assays for the presence of a mutant EGF receptor |
| 01/20/1998 | US5709996 Self-assembling recombinant papillomavirus capsid proteins |
| 01/20/1998 | US5709995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 01/20/1998 | US5709879 Vaccine compositions containing liposomes |
| 01/20/1998 | US5709865 Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53) |
| 01/20/1998 | US5709862 Immunology and antigens |
| 01/20/1998 | US5709861 Compositions for the delivery of antigens |
| 01/20/1998 | US5709860 Induction of cytotoxic T-lymphocyte responses |
| 01/20/1998 | US5709859 Complexes of fusion proteins; antitumor agent; antiinflammatory agents |
| 01/20/1998 | US5709858 To which they are capable of binding; specified amino acid sequences; medical diagnosis |
| 01/15/1998 | WO1998001754A1 Novel proteins within the type e botulinum neurotoxin complex |
| 01/15/1998 | WO1998001570A2 Mutated antibody-dependent infection enhancing domains of hiv |
| 01/15/1998 | WO1998001564A1 Hiv envelope polypeptides and vaccine |
| 01/15/1998 | WO1998001561A1 SUBUNIT VACCINE FOR $i(STREPTOCOCCUS EQUI) |
| 01/15/1998 | WO1998001559A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | WO1998001558A2 Protein and peptide vaccines for inducing mucosal immunity |
| 01/15/1998 | WO1998001550A2 Vaccine against gastro-intestinal nematodes |
| 01/15/1998 | WO1998001549A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | WO1998001539A1 Conditional immortalisation process for human tumour cells for producing a vaccine |
| 01/15/1998 | WO1998001462A2 Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 01/15/1998 | WO1998001460A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | WO1998001154A2 Treatment and diagnosis of infections of gram positive cocci |
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | WO1997040166A3 Simian-human hav having a chimeric 2c protein |
| 01/15/1998 | CA2260368A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/15/1998 | CA2259965A1 Hiv envelope polypeptides and vaccine |
| 01/15/1998 | CA2259961A1 Protein and peptide vaccines for inducing mucosal immunity |
| 01/15/1998 | CA2259618A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | CA2259154A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/14/1998 | EP0817864A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa |
| 01/14/1998 | EP0817858A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 01/14/1998 | EP0817855A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors |
| 01/14/1998 | EP0817854A2 Antigen presentation system based on retrovirus-like particles |
| 01/14/1998 | EP0817853A1 Infectious dna clone of the tick-borne encephalitis (tbe) virus; recombinant vaccine derived from the said clone and production of the said vaccine; and a pharmaceutical product containing a replicable nucleic acid |
| 01/14/1998 | EP0817852A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
| 01/14/1998 | EP0817851A2 Dna encoding human papilloma virus type 18 |
| 01/14/1998 | EP0817848A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells |
| 01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 01/14/1998 | EP0817839A1 Human dnase |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817650A1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 01/14/1998 | EP0817648A1 Vascular endothelial cell growth factor antagonists |
| 01/14/1998 | EP0817647A1 Treatment for verotoxin-producing escherichia coli |
| 01/14/1998 | EP0817644A1 Treatment of papillomavirus-associated lesions using interleukin-12 |
| 01/14/1998 | EP0817643A1 Compounds and compositions for delivering active agents |
| 01/14/1998 | EP0659276B1 Immunoassay for detecting collagen or collagen fragments |
| 01/14/1998 | EP0394277B1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/13/1998 | US5708163 Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
| 01/13/1998 | US5708155 Dna construct encoding a chimeric protein |
| 01/13/1998 | US5708149 Method for producing purified recombinant Haemophilus influenzae transferrin binding proteins |
| 01/13/1998 | US5708147 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 01/13/1998 | US5708146 Antibodies and drugs |